Navigation Links
Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT
Date:11/3/2011

9, breakfast symposium), and Long-term Clinical Data of Paccocath Technology, Preclinical Evidence, and Planned Cotavance DEB Peripheral Study Designs (Thursday, Nov. 10, luncheon symposium). The MEDRAD Interventional exhibit booth will include information on its broad range of devices and display products from Pathway Medical Technologies, a recent acquisition that places MEDRAD Interventional as an emerging leader in revascularization solutions.  

About Cotavance with Paccocath Technology

The Cotavance balloon catheter is to be used in percutaneous interventions for the treatment of peripheral arterial disease for balloon dilation of stenotic lesions in the iliac and infrainguinal arteries while applying paclitaxel to the vessel wall to inhibit restenosis. The Paccocath technology is a proprietary drug matrix applied to the balloon of an angioplasty catheter. The matrix consists of paclitaxel, long used in drug-eluting stents to treat cardiovascular disease, and a radiologic contrast agent, Ultravist® 370.(1) When the balloon is inflated to dilate the narrowed vessel, paclitaxel is delivered directly to the diseased area. The Cotavance catheter received CE Mark certification in Europe in 2011. MEDRAD Interventional is moving forward with the Investigational Device Exemption (IDE) process as one of the steps in gaining FDA approval for Cotavance product in the United States.

About MEDRAD

The cardiovascular products of MEDRAD, Inc. were merged with the endovascular products of Possis Medical to form MEDRAD Interventional. Focused on the research and development of advanced technologies, MEDRAD Interventional designs, manufactures and markets devices that enable interventional physicians to better see and treat coronary and vascular disease.

MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiolog
'/>"/>

SOURCE MEDRAD Interventional
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  Orexigen Therapeutics, Inc. (Nasdaq: ... Cannell has joined as Chief Commercial Officer. ... Contrave® /Mysimba™ (naltrexone HCl / bupropion HCl extended ... global commercial strategy, assuming responsibilities previously held by ... commercial effort through the U.S. launch of Contrave, ...
(Date:3/30/2015)... 2015 NiQ Health, "the ... the high level interface capabilities of their CarePlus™ ... The partnership between CarePlus™ and ClinicAll ... allows patients to choose the most appropriate alarm ... The advanced functionality of CarePlus™ allows patient alarms ...
(Date:3/30/2015)... , March 30, 2015  Edison Nation Medical, ... worldwide search for product innovations to assist seniors ... ideas uncovered during the 8-week search will be ... commercialization.  Invention ideas can be submitted through a ... through May 28, 2015. The objective ...
Breaking Medicine Technology:Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3
... BELL, Pa., Aug. 8, 2011 Inovio Pharmaceuticals, Inc. (NYSE AMEX: ... ended June 30, 2011. Total revenue was $2.4 million ... 2011, compared to $1.1 million and $2.5 million for the same ... and six months ended June 30, 2011, were $7.6 million and ...
... Aug. 5, 2011 Jury selection in the second trial ... begun in Clark County, Nevada. The Nevada Supreme Court lifted ... it was determined by the court that nurse David Hambrick, ... "does not possess the requisite skill, knowledge or experience to ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 9Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 10Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 11Second Trial in the Largest Hepatitis C Outbreak in U.S. Begins - Mainor Eglet Law Firm Files for Plaintiffs 2
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an ... six new treatment options for dealing with stubborn, unwanted fat. ... topical product. The other three technologies use devices to deliver ... freezing cold ( CoolSculpting ) to kill fat cells. (see: ... us to permanently remove unwanted fat," says Dr. Simon Ourian, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 A key ... neurological diseases plays an important role in the response ... scientists from the Icahn School of Medicine at Mount ... diseases have long been associated with inflammation, part of ... when immune cells home in to attack invaders like ...
(Date:3/30/2015)... Vancouver, BC (PRWEB) March 30, 2015 ... recently announced that the majority of cases taken up ... trial. This means that the lawyers help protect the ... through the tedious court process. The announcement comes across ... their primary job is to provide convenience to their ...
(Date:3/30/2015)... Jose, California (PRWEB) March 30, 2015 ... population and government efforts to develop and establish chronic ... management therapies. Growth in the market is poised to ... as a result of the increase in chronic health ... diseases, and rheumatoid arthritis, among others. While conventional treatment ...
(Date:3/30/2015)... March 30, 2015 On March 19th, ... Field, home of the Detroit Lions, LiveToBeSober.org hosted the ... recognized pastors, ministers and bishops as well as other ... the audience at the luncheon, including retired Detroit Lions ... Per Wickstrom and two survivors of their own personal ...
Breaking Medicine News(10 mins):Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2
... researchers has constructed a model that predicts how an ... airliners. ,The study, "Modeling the Worldwide Spread ... in the January issue of the journal PLoS Medicine. ... world's largest-scale epidemic simulation of its kind. ...
... suggests that TEMPE, a topical anesthetic spray has the ... with premature ejaculation and might be useful// as a ... in the February issue of the urology journal BJU ... studied 54 men with premature ejaculation, randomly assigning them ...
... Rs.350 million to provide health insurance to around 1.2 ... H.D. Kumaraswamy announced// here Wednesday. ,"We are aware ... thousands of families. We have decided to provide health ... has been fixed for the project this year," Kumaraswamy ...
... that a novel needle-free vaccine approach// is effective and ... of Alzheimer’s disease. ,The transdermal, or ... of preventing or treating the devastating neurodegenerative disease with ... ,The study was published online this week in The ...
... effective procedure to combat obesity in adolescents,// according to a ... first study to evaluate the lap band in patients under ... average lost about 50% of their excess weight by one ... issue of the Journal of Pediatric Surgery. Currently, the lap ...
... Women with a history of abuse by intimate partners ... women with no history of such abuse, according to ... plan. ,The higher costs and utilization continued ... Group Health, the University of Washington (UW), and the ...
Cached Medicine News:Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 2Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 3Health News:TEMPE Spray Delays Ejaculation 2Health News:Karnataka's Free Health Insurance to the Poor 2Health News:Transdermal Vaccine Effective in Treating Alzheimer's Disease in Mice 2Health News:Stomach Banding Surgery Effective for Adolescents 2Health News:Stomach Banding Surgery Effective for Adolescents 3Health News:Health Care Costs - Significant for Abused Women 2
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30)....
...
Lacrimal Cannula, Curved - Open End, 21gSize: 21g x 1-1/2"....
Medicine Products: